secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2021-10-19T23:59:59+00:00
Accession:  0001193125-21-302022
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace appoints Lisa Andrade as Class II director, replacing Evan Norton
---------------------------------------------------------------------------

- Evan Norton resigned as Class II director effective Nov 1, 2021; no disagreement cited.
- Lisa Andrade appointed as Class II director effective Nov 1, 2021, term through 2023 annual meeting.
- Andrade will serve on Audit and Compensation Committees.
- She receives a stock option with $185K grant-date fair value, monthly vesting over 3 years.
- Annual cash retainers: $40K board, $10K audit, $7,500 compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/d26236d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-302022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer